Phibro Animal Health Corporation provided consolidated earnings guidance for the year ending June 30, 2024. For the year, the company expects Net sales of $980 million to $1.02 billion, growth of 2%, Net income of $23 million to $28 million, a decline of 22% and Diluted EPS of $0.57 to $0.69, a decline of 22%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.41 USD | +0.22% | +0.88% | +58.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.98% | 746M | |
-12.83% | 78.51B | |
+25.12% | 3.71B | |
-0.14% | 3.27B | |
-1.21% | 1.64B | |
+14.53% | 1.64B | |
-18.97% | 1.36B | |
+2.73% | 1.34B | |
-6.82% | 1.22B | |
+4.02% | 1.12B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024